- Health, C.W. (1996) "Epidemiology and hereditary aspects of acute leukemia", In: Wiernik, P.H., Canellos, G.P., Dutcher, J.P. and Kyle, R.A., eds. Neoplastic Diseases of the Blood, 3rd ed. (Churchill-Livingstone, New York), p 177.
- Buchner, t. and Heinecke, A. (1996) "The role of prognostic factors in acute myeloid leukemia", Leukemia 10(Suppl. 1), S28-S29.
- Johnson, P.R., Hunt, L.P. and Yin, J.A. (1993) "Prognostic factors in elderly patients with acute myeloid leukaemia: development of a model to predict survival", Br. J. Haematol. 85, 300-306.
- Kuriyama, K., Tomonaga, M., Matsuo, T., et al. (1994) "Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplaisa. Japan adult leukaemia study group (JALSG)", Br. J. Haematol. 86, 767-773.
- Leith, C.P., Kopecky, K.J. and Godwin, J. (1997) "Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDRI) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A southwest oncology group study", Blood 89, 3323-3329.
- Dastugue, N., Payen, C., Lafage-Pochitaloff, M., et al. (1995) "Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group", Leukemia 9, 1491-1498.
- Bennett, J.M., Catovsky, D., Daniel, M.T., et al. (1985) "Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British cooperative group", Ann. Intern. Med. 103, 620-625.
- Greer, J.P., Baer, M.R. and Kinney, M.C. (1998) "Acute myelogenous leukemia", In: Lee, G.R. and Foerster, J., eds, Wintrobe's clinical hematology, 10th ed. (Lippincott Williams and Wilkins, Philadelphia), pp 2288-2290.
- Baudard, M., Marie, J.P., Cadiou, M., et al. (1994) "Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients", Br. J. Haematol. 86, 82-91.
- Ferrara, F. and Mirto, S. (1996) "Serum L.D.H. value as a predictor of clinical outcome in acute myelogenous leukaemia of the elderly", Br. J. Haematol. 92, 627-631.
- Lee, K.H., Lee, J.S., Suh, C.W., et al. (1996) "Prognostic factors of acute myelocytic leukemia: an analysis of 132 patients in a single institution", J. Korean Med. Sci. 11, 222-232.
- Tucker, J., Thomas, A.E., Gregory, W.M., et al. (1990) "Acute myeloid leukemia in elderly adults", Hematol. Oncol. 8, 13-21.
- Vidriales, M.B., Orfao, A., Lopez-Berges, M.C., et al. (1990) "Prognostic value of S-phase cells in AML patients", Br. J. Haematol. 89, 342-348.
- Champlin, R. and Gale, R.P. (1987) "Acute myelogenous leukemia: recent advances in therapy", Blood 69, 1551-1562.
- Lowenberg, B., Zittoun, R., Kerkhofs, H., et al. (1989) "On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European organization for research and treatment of cancer leukemia group", J. Clin. Oncol. 7, 1268-1274.
- Hiddemann, W., Kern, W., Schoch, C., et al. (1999) "Management of acute myeloid leukemia in elderly patients", J. Clin. Oncol. 17, 3569-3576.
- Mayer, R.J., Davis, R.B., Schiffer, C.A., et al. (1994) "Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and leukemia group B", N. Engl. J. Med. 6(331), 896-903.
- Witz, F, Sadoun, A, Perrin, M.C., et al. (1998) "A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM)", Blood 15(91), 2722-2730.
- Rowe, J.M., Andersen, J.W., Mazza, J.J., et al. (1995) "A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55-70 years of age) with acute myelogenous leukemia: a study of the eastern cooperative oncology group (E1490)", Blood 15(86), 457-462.
- Dombret, H., Chastang, C., Fenaux, P., et al. (1995) "A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML cooperative study group", N. Engl. J. Med. 22(332), 1678-1683.
- Stone, R.M., Berg, D.T., George, S.L., et al. (1995) "Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and leukemia group B", N. Engl. J. Med. 22(332), 1671-1677.
Prognostic Factors in Elderly Patients with Acute Myelogenous Leukemia: A Single Center Study in Japan
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.